In patients with community-acquired pneumonia (CAP), it is uncommon for the causative pathogen to be identified when initial antimicrobial therapy is prescribed. Thus, an empirical approach is generally taken, based on antimicrobial therapy which covers the major pathogens of CAP. Although...

Community-acquired pneumonia (CAP) is a common cause of morbidity and mortality worldwide and places a large burden on medical and economic resources, particularly if hospitalization is required. Indeed, it has been estimated that annual costs of inpatient treatment of patients with CAP...